← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1989Last known activity
Oct 31, 2025
Timeline
1950s
- Jan 1, 1955
Eastern Cooperative Oncology Group— Founded
Drugs by trial phase (186 distinct, 267 trials)
Phase 3 (110 own, 0 via acquisition)
Phase 2 (73 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Adenoma, Islet Cell
- Amyloidosis
- Anemia
- Anemia, Refractory
- Anemia, Refractory, with Excess of Blasts
- Anus Neoplasms
- Astrocytoma
- Breast Neoplasms
- Breast Neoplasms, Male
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Adenosquamous
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Islet Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Carcinosarcoma
- Central Nervous System Neoplasms
- Chondrosarcoma
- Choriocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Cystadenocarcinoma
- Cystadenocarcinoma, Serous
- Diarrhea
- Drug-Related Side Effects and Adverse Reactions
- Dysplastic Nevus Syndrome
- Endometrial Neoplasms
- Ependymoma
- Esophageal Neoplasms
- Fatigue
- Fibrosarcoma
- Fowlpox
- Gastrinoma
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Gestational Trophoblastic Disease
- Glioblastoma
- Glioma
- Glucagonoma
- Head and Neck Neoplasms
- Hemangiopericytoma
- Hodgkin Disease
- Hot Flashes
- Hydatidiform Mole
- Immunoblastic Lymphadenopathy
- Immunoglobulin Light-chain Amyloidosis
- Infections
- Infertility
- Insulinoma
- Kidney Neoplasms
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, Erythroblastic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Acute
- Leukemia, T-Cell
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Malignant Carcinoid Syndrome
- Medulloblastoma
- Melanoma
- Meningeal Neoplasms
- Meningioma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic-Myeloproliferative Diseases
Recent trials (50)
- NCT07040280Lead sponsorPhase 2Oct 31, 2025
- NCT07085728Lead sponsorPhase 2Aug 11, 2025
- NCT06724237Lead sponsorPhase 3Dec 1, 2024
- NCT05628623Lead sponsorPhase 2Feb 23, 2023
- NCT05289687Lead sponsorPhase 2Jun 16, 2022
- NCT02344810Lead sponsorPhase 1/Phase 2Jan 1, 2015
- NCT02031536Overall official - principal investigatorPhase 2Jan 1, 2014
- NCT02031536Lead sponsorPhase 2Jan 1, 2014
- NCT01863550Overall official - principal investigatorPhase 3Nov 1, 2013
- NCT01824901Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2013
- NCT01898494Lead sponsorPhase 2Aug 1, 2013
- NCT01824823Overall official - principal investigatorPhase 2Jul 1, 2013
- NCT01824836Overall official - principal investigatorN/AMay 1, 2013
- NCT01824836Lead sponsorN/AMay 1, 2013
- NCT01824875Lead sponsorPhase 2May 1, 2013
Details
- Founded
- Boston, MA, US Jan 1, 1955
- Last known activity
- Oct 31, 2025